Federal Register Final order: FDA is classifying hemoglobin A1c test system into Class 2 (special controls). The special controls are: 1. The device must have initial and annual standardization verification by a certifying glycohemoglobin standardization organization deemed acceptable by FDA. 2. The premarket notification submission must include performance testing to evaluate precision, accuracy, linearity and interference. To view this final order, click here.